Investing.com - Sophia Genetics (NASDAQ: SOPH) reported third quarter EPS of $-0.21, $0.08 better than the analyst estimate of $-0.29. Revenue for the quarter came in at $16.3M versus the consensus estimate of $15.63M.
Sophia Genetics's stock price closed at $3.86. It is up 14.20% in the last 3 months and up 109.78% in the last 12 months.
Sophia Genetics saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Sophia Genetics's stock price’s past reactions to earnings here.
According to InvestingPro, Sophia Genetics's Financial Health score is "good performance".
Check out Sophia Genetics's recent earnings performance, and Sophia Genetics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar